Full Text View
Tabular View
No Study Results Posted
Related Studies
Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children
This study is ongoing, but not recruiting participants.
Study NCT00621764   Information provided by Sanofi

First Received on February 12, 2008.   Last Updated on March 28, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Japanese Encephalitis
Hepatitis A
Additional conditions recognized in this trial
Encephalitis
Encephalitis, Japanese
Hepatitis
More general conditions related to this trial
Arbovirus Infections
Brain Diseases
Central Nervous System Diseases
Central Nervous System Infections
Central Nervous System Viral Diseases
Digestive System Diseases
Encephalitis, Arbovirus
Encephalitis, Viral
Enterovirus Infections
Flaviviridae Infections
Flavivirus Infections
Hepatitis, Viral, Human
Liver Diseases
Nervous System Diseases
Picornaviridae Infections
RNA Virus Infections
Virus Diseases
Sponsors listed in this trial
Sanofi Pasteur, a Sanofi Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services